101 – 110 of 123
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Targeting impulsivity in Parkinson's disease using atomoxetine
(
- Contribution to journal › Article
-
Mark
The incidence of Parkinson's disease in the North-East of England
(
- Contribution to journal › Article
-
Mark
Health-related quality of life in early Parkinson's disease : the impact of nonmotor symptoms
(
- Contribution to journal › Article
-
Mark
Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life
(
- Contribution to journal › Article
-
Mark
Quality of life and mild cognitive impairment in early Parkinson's disease : does subtype matter?
(
- Contribution to journal › Article
-
Mark
Mutant huntingtin is present in neuronal grafts in Huntington disease patients
(
- Contribution to journal › Article
-
Mark
Selective serotonin reuptake inhibition modulates response inhibition in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Prediction of manifest Huntington's disease with clinical and imaging measures : a prospective observational study
(
- Contribution to journal › Article
-
Mark
Molecular and functional definition of the developing human striatum
(
- Contribution to journal › Article